New artificial DNA structures can target and destroy cancer cells

FHS
August 18, 2023
12:42 pm

A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to specifically target cancerous cells.

Gedeon Richter becomes strategic investor of Formycon via equity investment – Biotech Investments

EQS-News: Formycon AG / Key word(s): Capital Increase Gedeon Richter becomes strategic investor of Formycon via equity investment 29.01.2024 / 22:15 CET/CEST The issuer is

January 30, 2024

Oncologists Express Conflicted Views About AI in Clinical Practice

Patients with cancer do not need a detailed understanding of artificial intelligence (AI), but they should consent to use of AI models during treatment, according

March 29, 2024

Drugmakers are losing crucial friends on Capitol Hill

WASHINGTON — Sen. Bob Menendez is the poster child for a pharmaceutical industry ally. He represents the industry stronghold of New Jersey, home to giants

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.